mortality/aging
• survive until E16.5-E18.5 but only 1 out of 314 mice produced was homozygous
• Background Sensitivity: survival to birth is decreased compared to homozygous mice on a mixed background that includes CD-1
|
hematopoietic system
• decreased proliferation potential
|
• accumulation of pro- and early basophilic erythroblasts in the fetal liver and reduction in the number of chromatophilic/orthochromatophilic erythroblasts and mature reticulocytes
|
• large accumulation of erythroblasts with uncompacted or micronuclei in the peripheral blood at E14.5
|
• impaired erythrocyte maturation in transplanted cells derived from E14.5 fetal livers
|
• marked reduction in Ter119 positive cells in the fetal liver and in red blood cells in the peripheral blood at E14.5
|
• in the peripheral blood at E14.5
|
• in the peripheral blood at E14.5
|
• decrease in the number of reticulocytes in the fetal liver
|
• accumulation of multipotent progenitors
|
growth/size/body
• by E14.5-E18.6
|
liver/biliary system
• increase in the presence of markers of DNA damage in the fetal liver at E16.5
|
integument
cellular
• basophilic and chromatophilic erythroblasts display an accumulation of cells in S phase suggesting a defect in DNA replication
|
• apoptotic erythroblasts are seen in the fetal liver
|
• decreased proliferation potential
|
• basophilic and chromatophilic erythroblasts display an accumulation of cells in S phase suggesting a defect in DNA replication
• high levels of markers for stalled fork replication are seen in early erythroblasts
|
homeostasis/metabolism
• basophilic and chromatophilic erythroblasts display an accumulation of cells in S phase suggesting a defect in DNA replication
• high levels of markers for stalled fork replication are seen in early erythroblasts
|